News Rebiotix microbiome drug success against C diff infection Patients suffering from a recurrent C diff infection have benefited from Rebiotix's microbiome treatment.
News New breakthrough designations for Roche's Alecensa and Actem... Alecensa and Roactemra are breakthroughs, says FDA.
News Janssen’s depression drug gains second breakthrough status Drug could help prevent some of the 41,000 suicides every year in US
News New Breakthrough status for Darzalex in earlier myeloma trea... Janssen's drug looking to gain bigger share in crowded myeloma market
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
